Company / Cash & Equivalents
CLOVER HEALTH INVESTMENTS, CORP. /DE Cash & Equivalents History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$78.3M
FY2025
5-year range
$78.3M / $300.0M
FY2021-FY2025
Trend
-59.8%
vs FY2024
Sector context
#120 of 148
Health Care
What the data says
CLOVER HEALTH INVESTMENTS, CORP. /DE's cash & equivalents of $78M is lower than 81% of companies in the Health Care sector (FY2025). Cash & Equivalents has fluctuated over the past 7 years, ranging from $0 in FY2019 to $300M in FY2021.
Based on SEC 10-K filings.
$78M in FY2025 with a 5-year CAGR of -3.2%.
Declined from $123M to $78M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -9.0%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 148This company $78.3M Sector average $1.2B
▼
-93.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.2%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 59.8% year-over-year.
- Ranks #120 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $78.3M | -59.8% |
| FY2024 | $194.5M | +58.3% |
| FY2023 | $122.9M | +18.4% |
| FY2022 | $103.8M | -65.4% |
| FY2021 | $300.0M | +224.8% |
| FY2020 | $92.3M | - |
| FY2019 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026